Pharmafile Logo
Pharmafocus logo
Advanced Search

Sinovac booster jab reverses antibody drop from Delta variant, study finds

September 6, 2021
Medical Communications, Research and Development, Sales and Marketing

Researchers have found that a booster shot of Sinovac’s COVID-19 vaccine reverses a decline in antibody activities against the Delta …

News

Israel to present COVID booster-shot data to FDA

September 6, 2021
Sales and Marketing

This month Israel will present COVID booster-shot data to the FDA, which is weighing White House plans to begin a …

News

COVID vaccine passports to start in England this month

September 6, 2021
Medical Communications, Sales and Marketing

The Vaccine Minister, Nadhim Zahawi, has confirmed that vaccine passports will be required in nightclubs and other indoor venues at …

News
nice_new_london_office_internal_2_88

Bimekizumab receives first positive health technology assessment worldwide

September 6, 2021
Sales and Marketing

NICE has published its final Technology Appraisal Guidance (TAG) recommending UCB’s BIMZELX (bimekizumab) as a treatment option for adults with …

News

Newron begins first potentially pivotal schizophrenia study

September 6, 2021
Sales and Marketing

Newron has initiated Study 008A, the first potentially pivotal study with evenamide in patients with schizophrenia.Study 008A, a four-week, randomised, …

News

WHO: Number of dementia sufferers to rise 40% to 78 million by 2030

September 3, 2021
Medical Communications

A new report from the WHO has predicted the number of people suffering from dementia is set to rise by …

News

NICE approves secukinumab for young people with severe plaque psoriasis

September 3, 2021
Medical Communications

NICE has approved secukinumab (Cosentyx) as an option for treating moderate to severe plaque psoriasis in people aged six to …

News

Novartis halts kidney transplant drug trial

September 3, 2021
Medical Communications

Novartis has announced that trials investigating CFZ533 (iscalimab) in kidney transplant patients has been halted after interim data show it …

News
astrazeneca_sign_sky

AstraZeneca’s Ultomiris approved for use on children in EU

September 3, 2021
Medical Communications, Research and Development

AstraZeneca has gained EU approval for its rare blood disorder drug, Ultomiris, for use in children. The drug was developed …

News

US Congress to investigate FDA’s approval of Biogen’s Alzheimer’s drug

September 3, 2021
Medical Communications

The US Congress has requested data and documents from the FDA in relation to its accelerated approval of the controversial …

News

Purdue pharma to pay billions for opioid pandemic but gains immunity in deal

September 2, 2021

A US judge has approved Purdue Pharma’s, the makers of Oxycontin, reorganisation plan, which will offer them immunity from any …

News

Risk of long COVID halved by vaccines, study finds

September 2, 2021
Medical Communications

Researchers at King’s College London have found that being fully vaccinated against COVID-19 not only cuts the risk of catching …

News

Moderna recall COVID vaccines after stainless steel contaminants found

September 2, 2021
Medical Communications

Moderna and Takeda Pharmaceutical on Wednesday said they are working with Japanese authorities to recall three batches of their COVID-19 …

News

FDA seeks new warnings on arthritis drugs

September 2, 2021
Medical Communications

The FDA has requested that Pfizer, Eli Lilly, and AbbVie include additional warnings on their arthritis drugs about the risks …

News
moderna_norwood_plant

Moderna submits data to FDA for COVID-19 vaccine booster

September 2, 2021

Moderna has initiated its submission to the FDA for the evaluation of a booster dose of the Moderna COVID-19 vaccine. …

News
andrei_r_-_shutterstock_1935537274_720

NICE and Cochrane to collaborate on living recommendations

September 1, 2021
Medical Communications, Research and Development

NICE has announced a collaboration with Cochrane, in which Cochrane will help deliver ‘living’ recommendations across the NICE guideline portfolio. …

News

Viper venom found to inhibit COVID virus from multiplying

September 1, 2021
Medical Communications, Research and Development

Brazilian researchers have found that a molecule in the venom of a jararacussu pit viper can prevent coronavirus reproduction. The …

News
annie-spratt-yiiz4olewg4-unsplash_1

AI test screens for COVID-19 26% faster than lateral flow tests

September 1, 2021
Research and Development

A University of Oxford-led study has shown that COVID-19 screening results were available 45 minutes after patients arrived in the …

News
moderna_norwood_plant

Fourth contaminated Moderna vial found in Japan

September 1, 2021
Medical Communications, Research and Development

A fourth contamination case in less than a week in Japan has been reported involving Moderna’s COVID-19 vaccine, which threatens …

News

NICE approves life-saving cholesterol drug for NHS

September 1, 2021
Research and Development

NICE has approved the ground-breaking cholesterol-lowering drug inclisiran, made by Novartis, for use on the NHS. This is an option …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026